Uncommon Descent Serving The Intelligent Design Community

WHY many “deadly” gene mutations prove harmless

Share
Facebook
Twitter
LinkedIn
Flipboard
Print
Email

Further to Rethinking the links between genes and disease, from Erica Check Hayden at Nature:

Many disease-association studies, particularly in recent years, have identified mutations as pathogenic simply because scientists performing analyses on a group of people with a disorder found mutations that looked like the culprit, but didn’t see them in healthy people. But it’s possible that they weren’t looking hard enough, or in the right populations. Baseline ‘healthy’ genetic data has tended to come mainly from people of European descent, which can skew results.

In August this year, MacArthur’s group published its analysis of ExAC data in Nature, revealing that many mutations thought to be harmful are probably not. In one analysis, the group identified 192 variants that had previously been thought to be pathogenic, but turned out to be relatively common. The scientists reviewed papers about these variants, looking for plausible evidence that they actually caused disease, but could find solid evidence for only nine of them. Most are actually benign, according to standards set by the American College of Medical Genetics and Genomics, and many have now been reclassified as such.

An obvious problem is people rushing to make drastic decisions based on misidentified associations. In any event, some genes only slightly increase a risk; not enough to bother much about. Further good news:

ExAC is quietly becoming a standard tool in medical genetics. Clinical labs around the world now check it before telling a patient that a particular glitch in their genome might be making them ill. If the mutation is common in ExAC, it’s unlikely to be harmful. Geneticist Leslie Biesecker at the US National Human Genome Research Institute in Bethesda, Maryland, says that his lab uses ExAC daily in patient care. “It’s a critical factor that we take into consideration for every variant,” he says. He and other geneticists are now embarking on a painstaking reckoning with the genetics literature that will probably take years.More.

Good. We all have enough real problems to worry about.

See also: Rethinking the links between genes and disease Nature: Each person has lurking in their genome an average of 54 mutations that are currently considered pathogenic — but that about 41 of these occur so frequently in the human population that they aren’t in fact likely to cause severe disease.

and

Protozoans with no dedicated stop codons

Follow UD News at Twitter!

Comments
OT:
Two Experiments in Abiogenesis - James Tour - Sept. 2016 Excerpt: The work by Carell and his colleagues illustrates another frustrating problem in prebiotic chemistry. One group publishes their results reporting products in low yields and unusable gross mixtures. Another group then uses those products, in their pure and abundant form, as their starting materials. Carell’s group used homochiral ribose, claiming that, “Ribose is generated from glycoaldehyde and formaldehyde, formed from an early atmosphere containing humid CO2.”3 This reaction provides only ribose traces in unusable mixtures. Carell and his coworkers assumed ribose as a given. They also used purified aminopyrimidines, relying on research that generated them from small molecules, such as guanidine and hydrogen cyanide. The published protocols on which they reply report equally troubling mixtures of products. No overall bookkeeping standards are maintained from one published work to another. The shortcomings of past generations are subsumed in current work without ever being acknowledged. “It is assumed,” Carell and his colleagues remark, “that life originated from a simple set of small molecules.”4 His work dispels any such illusions. Reckless general claims are a characteristic of the field.,,, http://inference-review.com/article/two-experiments-in-abiogenesis
bornagain77
October 14, 2016
October
10
Oct
14
14
2016
06:43 PM
6
06
43
PM
PDT
Of related interest to the finding that "many “deadly” gene mutations prove harmless", materialistic presumptions, particularly the materialistic presumption of common ancestry, also misled medical researchers in animal testing. Specifically, 92 percent of all drugs that are shown to be safe and effective in animal tests fail in human trials because they don’t work or are dangerous:
Animal Testing Is Bad Science: Point/Counterpoint Excerpt: The only reason people are under the misconception that animal experiments help humans is because the media, experimenters, universities and lobbying groups exaggerate the potential of animal experiments to lead to new cures and the role they have played in past medical advances.,,, The Food and Drug Administration (FDA) has noted that 92 percent of all drugs that are shown to be safe and effective in animal tests fail in human trials because they don’t work or are dangerous.,,, Physiological reactions to drugs vary enormously from species to species. Penicillin kills guinea pigs but is inactive in rabbits; aspirin kills cats and causes birth defects in rats, mice, guinea pigs, dogs, and monkeys; and morphine, a depressant in humans, stimulates goats, cats, and horses. http://www.peta.org/issues/animals-used-for-experimentation/animal-testing-bad-science.aspx
In fact, the following paper finds 'it is a striking paradox that chimpanzees are in fact not good models for many major human diseases/conditions'
Comparing the human and chimpanzee genomes: Searching for needles in a haystack – Ajit Varki1 and Tasha K. Altheide – 2005 Excerpt: The chimpanzee has also long been seen as a model for human diseases because of its close evolutionary relationship. This is indeed the case for a few disorders. Nevertheless, it is a striking paradox that chimpanzees are in fact not good models for many major human diseases/conditions (see Table 2) (Varki 2000; Olson and Varki 2003). http://genome.cshlp.org/content/15/12/1746.full
The money that has been wasted on animal testing because of the false assumption of common ancestry is enormous:
What scientific idea is ready for retirement? – Mouse Models Excerpt: A recent scientific paper showed that all 150 drugs tested at the cost of billions of dollars in human trials of sepsis failed because the drugs had been developed using mice. Unfortunately, what looks like sepsis in mice turned out to be very different than what sepsis is in humans. Coverage of this study by Gina Kolata in the New York Times incited a heated response from within the biomedical research community. AZRA RAZA – Professor of medicine and director of the MDS Centre, Columbia University, New York http://www.theguardian.com/science/2014/jan/12/what-scientific-idea-is-ready-for-retirement-edge-org
As far a medical diagnosis itself is concerned, Dr. Egnor holds that 'Evolutionary explanations by themselves are worthless to medicine. All medical treatments are based on detailed proximate explanations'.
Darwinian Medicine and Proximate and Evolutionary Explanations – Michael Egnor – neurosurgeon – June 2011 Excerpt: 4) Evolutionary explanations by themselves are worthless to medicine. All medical treatments are based on detailed proximate explanations. http://www.evolutionnews.org/2011/06/darwinian_medicine_and_proxima047701.html Against "Darwinian Medicine" - Michael Egnor - August 9, 2016 Excerpt: Darwinist Randolph Nesse has been peddling "Darwinian Medicine" for years.,,, He argues for integration of Darwinian science into medical school curricula,,, The very admission that Darwinism has had no role in medical science is a telling argument not for its inclusion, but for its irrelevance. Medical science is remarkably successful. Antibiotics, cybernetics, cancer chemotherapy, bone marrow transplants, hip replacements, heart transplants, and a host of near-miraculous advances have greatly extended our lifespan and improved the quality of our lives -- all without Darwin. Whether or not Darwinian hypotheses can be teased out of some medical advances, it is simply a fact that doctors and medical researchers pay no attention to Darwinian speculations in their work, and their work has been astonishingly successful. http://www.evolutionnews.org/2016/08/against_darwini103058.html
Another place that evolutionary assumptions have misled medical doctors has been with the false evolutionary assumption of vestigial organs:
Evolution’s “vestigial organ” argument debunked Excerpt: “The appendix, like the once ‘vestigial’ tonsils and adenoids, is a lymphoid organ (part of the body’s immune system) which makes antibodies against infections in the digestive system. Believing it to be a useless evolutionary ‘left over,’ many surgeons once removed even the healthy appendix whenever they were in the abdominal cavity. Today, removal of a healthy appendix under most circumstances would be considered medical malpractice” (David Menton, Ph.D., “The Human Tail, and Other Tales of Evolution,” St. Louis MetroVoice , January 1994, Vol. 4, No. 1). “Doctors once thought tonsils were simply useless evolutionary leftovers and took them out thinking that it could do no harm. Today there is considerable evidence that there are more troubles in the upper respiratory tract after tonsil removal than before, and doctors generally agree that simple enlargement of tonsils is hardly an indication for surgery” (J.D. Ratcliff, Your Body and How it Works, 1975, p. 137). The tailbone, properly known as the coccyx, is another supposed example of a vestigial structure that has been found to have a valuable function—especially regarding the ability to sit comfortably. Many people who have had this bone removed have great difficulty sitting. http://www.ucg.org/science/god-science-and-bible-evolutions-vestigial-organ-argument-debunked/
And whereas evolutionary assumptions have led to much needless medical malpractice, on the other hand, Intelligent Design, particularly the presumption that there are strict limits to what evolutionary processes can accomplish, is turning out to be very useful for medicine.
Guide of the Perplexed: A Quick Reprise of The Edge of Evolution – Michael Behe – August 20, 2014 Excerpt: If there were a second drug with the efficacy of chloroquine which had always been administered in combination with it (but worked by a different mechanism), resistance to the combination would be expected to arise with a frequency in the neighborhood of 1 in 10^40 — a medical triumph (over malaria). per evolution news and views Fighting Cancer with Intelligent Design – Casey Luskin – December 25, 2015 Excerpt: “In fighting antibiotic resistance, Darwin’s theory actually provides little guidance. Indeed, quite the opposite. As SUNY Professor of Neurosurgery Michael Egnor has written here, “Darwinism tells us that … bacteria survive antibiotics that they’re not sensitive to, so non-killed bacteria will eventually outnumber killed bacteria. That’s it.” To create drugs that outsmart evolving bacteria or cancer cells, biomedical researchers must use a process of intelligent design. They create drug cocktails that bank upon the fact that there are limits to how much living things can evolve on their own. Far from being evidence for Darwinian theory, antibiotic resistant bacteria point to what Michael Behe has called “the edge of evolution,” beyond which unguided Darwinian processes are powerless.” In simple terms, Darwinian evolution tends to work fine when only one mutation is needed to give an advantage. But when you need multiple mutations to gain an advantage, the process tends to get stuck. By throwing lots of antibiotic drugs at an organism, we force it to evolve lots of mutations — more than Darwinian evolution can produce — in order to survive. In this way, we can beat antibiotic-resistant microbes.,,, Dr. M. William Audeh at UCLA School of Medicine. He makes the same point with regard to fighting cancer.,,, He says we kill cancer cells by using many (“combinations of”) drugs — more than they can possibly evolve resistance to. When he says that we can “overcome the adaptive potential of the population,” he means there are limits to how much cancer cells can evolve. If we intelligently design combinations of drugs that would require more mutations than could possibly arise via Darwinian evolution, then we kill cancer cells before they evolve mutations to evade our therapy techniques. - per evolution news and views
The multiple drug cocktail that has been so effective in controlling HIV uses much the same strategy of being beyond the ‘edge of evolution’ that Dr. Behe has elucidated:
When taking any single drug, it is fairly likely that some mutant virus in the patient might happen to be resistant, survive the onslaught, and spawn a resistant lineage. But the probability that the patient hosts a mutant virus that happens to be resistant to several different drugs at the same time is much lower.,,, it “costs” a pest or pathogen to be resistant to a pesticide or drug. If you place resistant and non-resistant organisms in head-to-head competition in the absence of the pesticide or drug, the non-resistant organisms generally win.,,, This therapy has shown early, promising results — it may not eliminate HIV, but it could keep patients’ virus loads low for a long time, slowing progression of the disease. http://evolution.berkeley.edu/evolibrary/article/medicine_04
bornagain77
October 14, 2016
October
10
Oct
14
14
2016
03:02 PM
3
03
02
PM
PDT
Of related note:
Gene Therapy for Genetic Disorders Excerpt: Severe Combined Immune Deficiency (ADA-SCID) ADA-SCID is also known as the bubble boy disease.,,, The therapeutic gene called ADA was introduced into the bone marrow cells of such patients in the laboratory, followed by transplantation of the genetically corrected cells back to the same patients. The immune system was reconstituted in all six treated patients without noticeable side effects, who now live normal lives with their families without the need for further treatment. ,,, Hemophilia Patients born with Hemophilia are not able to induce blood clots and suffer from external and internal bleeding that can be life threatening. In a clinical trial conducted in the United States , the therapeutic gene was introduced into the liver of patients, who then acquired the ability to have normal blood clotting time. The therapeutic effect however, was transient because the genetically corrected liver cells were recognized as foreign and rejected by the healthy immune system in the patients.,,, http://www.asgct.org/about_gene_therapy/diseases.php
bornagain77
October 14, 2016
October
10
Oct
14
14
2016
03:01 PM
3
03
01
PM
PDT

Leave a Reply